Biofilm Development on Urinary Catheters Promotes the Appearance of Viable but Nonculturable Bacteria.
Anti-Bacterial Agents
/ pharmacology
Bacteria
/ classification
Biofilms
/ growth & development
Colony Count, Microbial
Escherichia coli
/ growth & development
Hydrogels
Latex
Microbial Viability
Proteus mirabilis
/ growth & development
Pseudomonas aeruginosa
/ growth & development
Silicones
Surface Properties
/ drug effects
Urinary Catheters
/ microbiology
biofilms
silver
urinary catheters
viable but nonculturable
Journal
mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231
Informations de publication
Date de publication:
23 03 2021
23 03 2021
Historique:
entrez:
24
3
2021
pubmed:
25
3
2021
medline:
1
10
2021
Statut:
epublish
Résumé
Catheter-associated urinary tract infections have serious consequences, for both patients and health care resources. Much work has been carried out to develop an antimicrobial catheter. Although such developments have shown promise under laboratory conditions, none have demonstrated a clear advantage in clinical trials. Using a range of microbiological and advanced microscopy techniques, a detailed laboratory study comparing biofilm development on silicone, hydrogel latex, and silver alloy-coated hydrogel latex catheters was carried out. Biofilm development by
Identifiants
pubmed: 33758085
pii: mBio.03584-20
doi: 10.1128/mBio.03584-20
pmc: PMC8092313
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Hydrogels
0
Latex
0
Silicones
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2021 Wilks et al.
Références
J Med Microbiol. 2009 Oct;58(Pt 10):1367-1375
pubmed: 19556373
Appl Environ Microbiol. 2010 Mar;76(5):1669-73
pubmed: 19966018
Nat Rev Microbiol. 2017 Aug;15(8):453-464
pubmed: 28529326
Curr Microbiol. 2000 Aug;41(2):120-5
pubmed: 10856378
Eur Urol. 2015 Aug;68(2):173-4
pubmed: 25774008
Curr Microbiol. 1996 Jul;33(1):1-5
pubmed: 8661684
Am J Infect Control. 2004 Dec;32(8):445-50
pubmed: 15573050
Acta Biomater. 2015 Mar;15:127-38
pubmed: 25541344
J Bacteriol. 2018 Sep 24;200(20):
pubmed: 30082460
J Infect Chemother. 2000 Jun;6(2):121-5
pubmed: 11810550
Emerg Infect Dis. 2001 Mar-Apr;7(2):342-7
pubmed: 11294737
Br J Nurs. 2006 Jun 8-21;15(11):598-603
pubmed: 16835528
Urology. 2011 Aug;78(2):334-9
pubmed: 21820571
J Clin Microbiol. 2012 Apr;50(4):1376-83
pubmed: 22278835
Am J Med. 1998 Sep;105(3):236-41
pubmed: 9753027
BMC Biol. 2017 Dec 21;15(1):121
pubmed: 29262826
Lancet. 2012 Dec 1;380(9857):1927-35
pubmed: 23134837
J Hosp Infect. 2008 Aug;69(4):350-60
pubmed: 18550219
PLoS One. 2015 Oct 30;10(10):e0141711
pubmed: 26516766
Environ Microbiol. 2018 Jun;20(6):2038-2048
pubmed: 29457686
Urol Res. 2009 Apr;37(2):89-93
pubmed: 19189089
Arch Intern Med. 2000 Sep 25;160(17):2670-5
pubmed: 10999983
J Med Microbiol. 2007 Nov;56(Pt 11):1549-1557
pubmed: 17965358
Water Sci Technol. 2003;47(5):105-16
pubmed: 12701914
Front Microbiol. 2014 Jun 02;5:258
pubmed: 24917854
J Hosp Infect. 2005 Aug;60(4):298-303
pubmed: 15936115
Infect Immun. 2001 Jul;69(7):4572-9
pubmed: 11402001
Am J Infect Control. 2012 Nov;40(9):854-9
pubmed: 22325732
Ann Intern Med. 2006 Jan 17;144(2):116-26
pubmed: 16418411
FEMS Microbiol Lett. 2007 Mar;268(1):16-21
pubmed: 17250761
Int J Antimicrob Agents. 2004 Mar;23 Suppl 1:S75-8
pubmed: 15037331
J Control Release. 2015 Mar 28;202:57-64
pubmed: 25639970
Clin Microbiol Infect. 2012 Jul;18(7):E259-61
pubmed: 22578149
Microb Ecol. 2009 Jul;58(1):56-62
pubmed: 19043657
J Antimicrob Chemother. 2013 Aug;68(8):1812-7
pubmed: 23515246
Appl Environ Microbiol. 1995 Jul;61(7):2624-30
pubmed: 7618874
Lett Appl Microbiol. 1997 Mar;24(3):203-6
pubmed: 9080700
Clin Microbiol Rev. 2008 Jan;21(1):26-59
pubmed: 18202436
Arch Intern Med. 2004 Apr 26;164(8):842-50
pubmed: 15111369
mBio. 2018 Apr 17;9(2):
pubmed: 29666286
Antimicrob Agents Chemother. 1999 Dec;43(12):2990-5
pubmed: 10582894